Siegfried Holding AG (SFZN) CHF21.2

Sell:1,026.00 CHFBuy:1,030.00 CHF4.00 CHF (0.39%)

Prices delayed by at least 15 minutes
Sell:1,026.00 CHF
Buy:1,030.00 CHF
Change:4.00 CHF (0.39%)
Deal now
Prices delayed by at least 15 minutes
Sell:1,026.00 CHF
Buy:1,030.00 CHF
Change:4.00 CHF (0.39%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Siegfried Holding AG is a Switzerland-based life sciences company which is active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and sterile. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States, China, and Spain.

Key people

Reto Suter
Interim Chief Executive Officer, Chief Financial Officer, Member of the Executive Committee
Irene Wosgien
Chief Human Resource Officer
Juergen Roos
Chief Scientific Officer, Member of the Executive Committee
Christian Dowdeswell
Chief Business Officer Drug Substances, Member of the Executive Committee
Marcel Imwinkelried
Chief Operating Officer Drug Products, Member of the Executive Committee
Henrik Krupper
Chief Operating Officer Drug Substances, Member of the Executive Committee
Marianne Spaene
Chief Business Officer, Member of the Executive Committee
Andreas Casutt
Independent Non-Executive Chairman of the Board of Directors
Martin Schmid
Independent Non-Executive Vice Chairman of the Board of Directors
Alexandra Brand
Non-Executive Independent Member of the Board of Directors
Wolfram Carius
Non-Executive Independent Member of the Board of Directors
Elodie Carr-cingari
Non-Executive Independent Member of the Board of Directors
Click to see more

Key facts

  • EPIC
    -
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CH0014284498
  • Market cap
    CHF 4.63bn
  • Employees
    3,797
  • Shares in issue
    4.51m
  • Exchange
    SIX Swiss Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.